The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Self-citationThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Cited by
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Glutathione dysregulation and the etiology and progression of human diseases
Ballatori, N., Krance, S. M., Notenboom, S., Shi, S., Tieu, K., & Hammond, C. L. (2009) · bchm · doi:10.1515/bc.2009.033 · Cited by 1,114
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
The Blood-Testis Barrier and Its Implications for Male Contraception
Cheng, C. Y., & Mruk, D. D. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.002790 · Cited by 927
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
“In addition to structural elements assuring tightness of the BBB, transport systems and drug-metabolizing enzymes (including cytochrome P450 hemoproteins and uridine diphosphate glucuronosyltransferases) provide an enzymatic barrier (Lee et al. 2001; Leslie et al. 2005).”
BackgroundNRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 869
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
“Similarly, MRP1 in the placenta may protect the developing fetus from xenobiotics and help prevent the fetal accumulation of endobiotics, such as E217 G (287, 479).”
BackgroundInfluentialSelf-citationDermauw, W., & Van Leeuwen, T. (2014) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2013.11.001 · Cited by 631
Scholz, S., Fischer, S., Gündel, U., Küster, E., Luckenbach, T., & Voelker, D. (2008) · Environmental Science and Pollution Research · doi:10.1007/s11356-008-0018-z · Cited by 593
Szakács, G., Váradi, A., Özvegy-Laczka, C., & Sarkadi, B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.010 · Cited by 569
To Scale or Not to Scale: The Principles of Dose Extrapolation
Sharma, V., & McNeill, J. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00267.x · Cited by 544
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Peters, C., & Brown, S. (2015) · Bioscience Reports · doi:10.1042/bsr20150089 · Cited by 492
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Callaghan, R., Luk, F., & Bebawy, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056176 · Cited by 453
Robey, R. W., To, K. K. K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., & Bates, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.003 · Cited by 449
Chronic Kidney Disease and Exposure to Nephrotoxic Metals
Orr, S., & Bridges, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051039 · Cited by 434
Choudhuri, S., & Klaassen, C. D. (2006) · International Journal of Toxicology · doi:10.1080/10915810600746023 · Cited by 415
Gandhi, N. S., Tekade, R. K., & Chougule, M. B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.001 · Cited by 394
Ishimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379
Okawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T. W., & Yamamoto, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.185 · Cited by 387
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P., & Kumar, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s267383 · Cited by 384
Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1
Johnson, Z. L., & Chen, J. (2017) · Cell · doi:10.1016/j.cell.2017.01.041 · Cited by 375
Transport of glutathione and glutathione conjugates by MRP1
Cole, S. P. C., & Deeley, R. G. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.008 · Cited by 369
Self-citationCole, S. P. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.609248 · Cited by 361
Self-citationMannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Natural products as multidrug resistance modulators in cancer
Kumar, A., & Jaitak, V. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.027 · Cited by 334
Abou-Donia, M. B., El-Masry, E. M., Abdel-Rahman, A. A., McLendon, R. E., & Schiffman, S. S. (2008) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287390802328630 · Cited by 333
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Creixell, M., & Peppas, N. A. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.013 · Cited by 331
Tang, X., Wang, H., Fan, L., Wu, X., Xin, A., Ren, H., & Wang, X. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.008 · Cited by 325
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
Ballatori, N., Krance, S. M., Marchan, R., & Hammond, C. L. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.004 · Cited by 318
Glutathione in Cancer Cell Death
Ortega, A. L., Mena, S., & Estrela, J. M. (2011) · Cancers · doi:10.3390/cancers3011285 · Cited by 317
Matsson, P., Pedersen, J. M., Norinder, U., Bergström, C. A. S., & Artursson, P. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9896-0 · Cited by 316
Metabolism, toxicity and anticancer activities of arsenic compounds
Khairul, I., Wang, Q. Q., Jiang, Y. H., Wang, C., & Naranmandura, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14733 · Cited by 300
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Huls, M., Brown, C. D. A., Windass, A. S., Sayer, R., van den Heuvel, J. J. M. W., Heemskerk, S., Russel, F. G. M., & Masereeuw, R. (2008) · Kidney International · doi:10.1038/sj.ki.5002645 · Cited by 293
Polyphenols journey through blood-brain barrier towards neuronal protection
Figueira, I., Garcia, G., Pimpão, R. C., Terrasso, A. P., Costa, I., Almeida, A. F., Tavares, L., Pais, T. F., Pinto, P., Ventura, M. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11512-6 · Cited by 290
Drug transporters in the human blood‐placental barrier
Vähäkangas, K., & Myllynen, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00336.x · Cited by 289
Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)
Deeley, R. G., & Cole, S. P. C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.036 · Cited by 284
Self-citationMultidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274
Transport of Inorganic Mercury and Methylmercury in Target Tissues and Organs
Bridges, C. C., & Zalups, R. K. (2010) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937401003673750 · Cited by 265
Strazielle, N., & Ghersi-Egea, J. F. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300518e · Cited by 263
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Structural Simplification of Natural Products
Wang, S., Dong, G., & Sheng, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00504 · Cited by 254
Liu, X. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-7647-4_2 · Cited by 254
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.005 · Cited by 249
“…fluid barrier, blood-testis barrier, and blood-placental barrier) (Aye and Keelan, 2013; Campos et al., 2012; Hartz and Bauer, 2011; Leslie et al., 2005; Robillard et al., 2012), excretory tissues (liver and kidney) (Choi and Yu, 2014) and absorption tissues (intestine and colon)…”
BackgroundHuman skeletal muscle drug transporters determine local exposure and toxicity of statins
Knauer, M. J., Urquhart, B. L., Meyer zu Schwabedissen, H. E., Schwarz, U. I., Lemke, C. J., Leake, B. F., Kim, R. B., & Tirona, R. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.203596 · Cited by 222
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152
Comparison of mechanistic transport cycle models of ABC exporters
Szöllősi, D., Rose-Sperling, D., Hellmich, U. A., & Stockner, T. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.10.028 · Cited by 107
Hanssen, K. M., Haber, M., & Fletcher, J. I. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100795 · Cited by 102
Minocha, M., Khurana, V., Qin, B., Pal, D., & Mitra, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.028 · Cited by 82
“oral absorption and provides a mechanism for drug elimination (Leslie et al., 2005; Shugarts and Benet, 2009).”
BackgroundEfflux and uptake transporters as determinants of statin response
Rodrigues, A. C. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003713519 · Cited by 64
“These transporters act to limit the access of drugs to protected tissue compartments, and to eliminate drugs and metabolites via bile [4].”
BackgroundResearch and development of drug delivery systems based on drug transporter and nano-formulation
Peng, Y., Chen, L., Ye, S., Kang, Y., Liu, J., Zeng, S., & Yu, L. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.02.004 · Cited by 62
In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity
Chieli, E., Romiti, N., Rodeiro, I., & Garrido, G. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.07.017 · Cited by 54
Cannon, R. E., Richards, A. C., Trexler, A. W., Juberg, C. T., Sinha, B., Knudsen, G. A., & Birnbaum, L. S. (2020) · Environmental Health Perspectives · doi:10.1289/ehp5884 · Cited by 43
“Their localization and expression levels in liver and kidney also serve to eliminate harmful agents from the body (Leslie et al. 2005).”
Zaja, R., Caminada, D., Lončar, J., Fent, K., & Smital, T. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.11.001 · Cited by 34
Structural insights into binding-site access and ligand recognition by human ABCB1
Kurre, D., Dang, P. X., Le, L. T. M., Gadkari, V. V., & Alam, A. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00361-z · Cited by 25
Tumorigenic Epithelial Stem Cells and Their Normal Counterparts
Donnenberg, V. S., Luketich, J. D., Landreneau, R. J., DeLoia, J. A., Basse, P., & Donnenberg, A. D. (2007) · Cancer Stem Cells · doi:10.1007/2789_2007_054 · Cited by 25
Metadata
- Authors
- Leslie, E. M., Deeley, R. G., & Cole, S. P. C.
- Venue
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 204
- Issue
- 3
- Pages
- 216-237
- ISSN
- 0041-008X (ISSN-L)
- OpenAlex
- W2081213990
- Cited by
- 1,406
- References
- 204
- FWCI
- 23.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.